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Abstract
Background: 112 patients who received small and medium sized St.Jude Regent heart valves (19-25 mm) at 7
Scandinavian centers were studied between January 2003 and February 2005 to obtain non-invasive data regarding
the hemodynamic performance at rest and during Dobutamine stress echocardiography (DSE) testing one year
after surgery.
Material and methods: 46 woman and 66 men, aged 61.8 ± 9.7 (18-75) years, were operated on for aortic
regurgitation (17), stenosis (65), or mixed dysfunction (30). Valve sizes were 19 mm (6), 21 mm (33), 23 mm (41), 25
mm (30). Two patients receiving size 27 valves were excluded from the hemodynamic evaluation. Pledgets were
used in 100 patients, everted mattress in 66 and simple interrupted sutures in 21. Valve orientation varied and was
dependent on the surgeons’ choice. 34 patients (30.4%) underwent concomitant coronary artery surgery.
Results: There were two early deaths (1.8%) and three late deaths, one because of pancreatic cancer. Late events
during follow-up were: non structural dysfunction (1), bleeding (2), thromboembolism (2). At one year follow up
93% of the patients were in NYHA classes 1-2 versus 47.8% preoperatively.
Dobutamine stress echocardiography (DSE) was performed in a total of 66 and maximal peak stress was reached in
61 patients.
During DSE testing, the following statistically significant changes took place: Heart rate increased by 73.0%, cardiac
output by 85.5%, left ventriclular ejection fraction by 19.6%, and maximal mean prosthetic transvalvular gradient by
133.8%, whereas the effective orifice area index did not change.
Left ventricular mass fell during one year from 215 ± 63 to 197 ± 62 g (p < 0.05).
Conclusion: The Dobutamine test induces a substantial stress, well suitable for echocardiographic assessment of
prosthesis valve function and can be performed in the majority of the patients. The changes in pressure gradients
add to the hemodynamic characteristics of the various valve sizes.
In our patients the St. Jude Regent valve performed satisfactory at rest and under pharmacological stress situation.
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Introduction
The current increase in life expectancy implies increas-
ing need for small and medium size valve replacement
since the augmented number of aortic stenosis in the
elderly is frequently accompanied by a narrow aortic
root. Optimal hemodynamic performance of the valve
prosthesis is particularly important in this setting [1,2].
Bileaflet mechanical valves are considered good long-
term substitutes, but are still undergoing improvements.
As for their assessment, dobutamine stress echocardio-
graphy (DSE) has emerged as a measure of the valve
hemodynamics adding to the information obtained at
rest [3-12]. However, its diagnostic role in this context
needs to be further defined.
The purpose of the present multicenter study was to
investigate the performance of small and intermediate
sizes of the St. Jude Medical Regent aortic valve, with
respect to EOA at various stress levels. This prosthesis
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represents the recent generation of a bileaflet mechani-
cal valve. This would, along with previous results [13],
contribute to a large scale assessment. Furthermore, the
study investigated the hemodynamic response to dobu-
tamine stress related to the size of normally functioning
valves. The responses might supplement their hemody-
namic characteristics which need to be assessed before
an abnormal response to stress can be defined.
Material and methods
Patient Population
A total of 112 patients (46 women and 66 male) under-
going surgery for aortic stenosis (n = 65), aortic regurgi-
tation (n = 17) or both (n = 30) between January 2003
and February 2005 at seven Scandinavian centers were
included in the study. Valve sizes were 19 mm (6), 21
mm (33), 23 mm (41), 25 mm (30). Two patients receiv-
ing size 27 valves were excluded from the hemodynamic
evaluation. Pledgets were used in 100 patients, everted
mattress in 66 and simple interrupted sutures in 21.
Valve orientation varied and was dependent on the sur-
geons’ choice. 34 patients (30.4%) underwent concomi-
tant coronary artery surgery. Concomitant coronary
artery bypass surgery was performed in 34 patients. The
age was 61.8 ± 9.7 years (mean-SD), range 18-75 years.
Clinically, 99 patients could be evaluated at follow-up
one year following surgery: two patients were excluded
due to valve size 27 mm, there were two early and three
late deaths, two patients developed Hodgkin’s disease
and there were missing data in four patients.
Study design
Standard echocardiographic and Doppler examinations
were performed preoperatively, at discharge and one
year after the operation at each of the seven centers. In
addition, DSE was performed at five centers one year
after the operation.
Echocardiographic recordings
Recordings in the parasternal view were obtained of left
ventricular size with measurements of intraventricular
septum and posterior wall thickness at end-diastole. Left
ventricular outflow tract diameter was reported as the
dimension just below the prosthetic valve during early
systole. Peak and mean velocities in the left ventricular
outflow tract was measured from the apical position.
Cardiac output was calculated as: CO (l/min) = VTI
LVOT × CSA × HR, were VTI LVOT is the velocity time
integral in the left ventricular outflow tract, CSA (ot) is
the left ventricular outflow tract cross section area, and
HR is heart rate.
Additionally flow velocities across the valve were mea-
sured. The prosthetic effective orifice area was calcu-
lated as: EOA (cm2) = CSA (0t) × VTI (ot)/VTI ao).
EOA index : EOA/BSA (cm
2/m2). Performance index
was calculated as: PI = EOA/MOA. MOA is manufac-
ture orifice area.
Dobutamine stress protocol
A standard Dobutamine stress echocardiography (DSE)
protocol was performed according to the Mayo clinic
protocol (14), starting at a Dobutamine infusion rate of
5 μg/kg/min body weight. The dosage was increased
every 5 minutes to 10, 15, 20, 25 and 30 μg/kg/min.
Dobutamine stress was discontinued according to estab-
lished criteria [14]. Blood pressure and 12- lead electro-
cardiograms were recorded at baseline and at the end of
each stage. Images were obtained in the standard para-
sternal (long and short axis) and apical (2-4-5 chamber
and long axis) views. Standard 2 dimension, M mode
and Doppler views were recorded at baseline and at the
end of the stress protocol.
The Dobutamine stress test was performed whenever
available.
Statistical analysis
Data are presented as mean ± SD. Analysis of variance
for repeated measurements were performed with valve
size as group factors and time (i.e. before and after the
operation or before and during stress). Student t tests
for comparison of groups and for comparison of paired
data were used whenever appropriate. P < 0.05 was con-
sidered significant.
Consent
Written informed consent to participate in this study
was obtained from each patient. A written consent is
available for review by the Editot-in-Chif of this journal.
The study was approved by the Regional ethical
committees.
Results
There were two early deaths (1.8%). One patient was
reoperated for bleeding. The mean follow-up time was
12.3 ± 6.0 months. During follow- up three patients
died, one due to a pancreatic carcinoma. Late events
during follow-up were: non structural dysfunction (1),
bleeding (2), thromboembolism (2).
At follow up, 93 out of 99 patients (94%) were in
NYHA classes’ 1-2, versus 47.8% preoperatively. Echo-
cardiographic data before surgery, at discharge and one
year after operation is presented in Tables 1 and 2. Left
ventricular mass was significantly reduced (p < 0.05)
after valve replacement, while no significant changes
were observed in left ventricular dimensions or ejection
fraction (EF). The transvalvular mean pressure gradient
was markedly reduced. The only mild residual mean
gradients demonstrated a decrease with increasing valve
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size; 11.4 ± 6.2 mmHg, 9.2 ± 6.6 mmHg, 7.7 ± 3.3
mmHg and 6.0 ± 2.8 mmHg in the sizes of 19, 21,
23 and 25 mm, respectively. Their corresponding EOA
indices were 1.0 ± 0.4, 1.0 ± 0.2, 1.0 ± 0.3 and 1.4 ±
0.6 cm2/m2.
DSE was performed in 66 patients. There were no ser-
ious complications. Maximal peak stress was reached in
61 patients (93%). The test had to be stopped before
peak stress was reached in five patients, due to arrhyth-
mia, chest pain or decrease in blood pressure.
The data obtained during DSE are presented in tables 3
and 4. During DSE heart rate increased on average by
73%, CO by 85.5% and the mean transvalvular gradient
by 134%, whereas the EOA did not change significantly.
The gradient at peak stress varied according to valve
size whereas EOA index did not.
Discussion
Hemodynamic properties of small sized aortic pros-
theses have been questioned, due to the possibility of
various degrees of hemodynamic functional obstruction
[1,2]. Valve prostheses may demonstrate acceptable
hemodynamic performance at rest. Additionally, a rise
in stroke volume during exercise may increase the pres-
sure drop across the valve and unmask suboptimal valv-
ular function. The hemodynamic performance of aortic
valve replacement should therefore be evaluated under
various cardiac flow conditions. In this multicenter
study hemodynamic evaluation of small mechanical
prostheses in the aortic position was performed by
transthoracic echocardiography at rest and during DSE.
Stress echocardiography is the combination of 2D
echocardiography with a physical, pharmacological or
electrical stress [15,16]. Stress echocardiography has
been regarded as an important tool in the field of non-
invasive diagnosis of coronary artery disease [17,18] and
in patients with suspected severe aortic stenosis with
low aortic gradients secondary to low cardiac output
[19,20].
DSE has additionally been used to examine patients
with aortic valve replacement [3-12], mitral valve repla-
cement [20] and double valve replacement. In patients
undergoing aortic valve replacement, DSE is an accurate,
safe and readily available method to evaluate prostheses
hemodynamics [3-12] and to monitor the expected left
ventricular hypertrophy regression [12].
The present study demonstrates that DSE can be
safely performed in patients one year following heart
valve replacement. We used a standard Mayo protocol
[14], starting Dobutamine infusion at 5 μg/kg/min. In
some previous studies, Dobutamine has been adminis-
tered to a maximum dose of 20 μg/kg/min [3,4,6,7]. In
most of the recent studies a maximum of 40 μg/kg/min
was most often used. Co-administration with atropine
[15] has not been used in the studies evaluating prosthe-
sis hemodynamics.
Table 1 Left ventricle dimensions, mass and ejection
fraction preoperatively, at discharge and after one year
Preoperatively Discharge One year p
LVDD (mm): 53 ± 9 51 ± 10 50 ± 7 ns
IVD (mm): 13 ± 2 8 ± 1 9 ± 1 ns
LVPW (mm): 11 ± 2 12 ± 2 11 ± 2 ns
Mass (g): 265 ± 85 260 ± 95 214 ± 63 < 0.05
Mass/BSA (g/m2): 139 ± 42 137 ± 43 112 ± 30 < 0.05
EF (%): 55.5 ± 10.8 54.3 ± 12.0 58.4 ± 9.5 ns
Mean ± SD, LVDD; left ventricle diastolic dimension,, IVD; intraventricular
septum diastolic dimension, LVPW; left ventricle posterior wall dimension,
mass; left ventricle mass, Mass/BSA; left ventricle mass index, EF; left ventricle
ejection fraction.
Table 2 Hemodynamic variables preoperatively, at discharge and after one year
Preoperatively Discharge One year p
Peak gradient (mmHg): 71.7 ± 32.6 16.8 ± 9.1 5.9 ± 9.0 < 0.01
Mean gradient mmHg): 47.9 ± 22.8 8.7 ± 5.0 8.0 ± 4.8 < 0.01
EOA (cm2): 1.6 ± 1.8 2.0 ± 0.7 2.0 ± 0.7 ns
EOA index (cm2/m2): 0.8 ± 1.0 1.1 ± 0.4 1.1 ± 0.3 ns
Performance index: 0.3 ± 0.2 0.6 ± 0.2 0.6 ± 0.2 < 0.01
CO (l/min): 5.9 ± 1.6 5.8 ± 2.0 5.5 ± 1.4 < 001
CI (l/min/m2): 3.1 ± 0.8 3.1 ± 1.0 2.9 ± 0.6 0.01
HR (beat/min): 70 ± 11 81 ± 13 65 ± 13 < 0.01
EOA: effective orifice area, EOA index; effective orifice area index, CO; cardiac output, CI; cardiac index, HR; heart rate.
Table 3 Hemodynamic variables at rest and during
maximal stress (n = 61)
Rest Peak stress p
Heart rate (beat/min): 63 ± 11 109 ± 21 < 0.001
CO (l/min): 5.5 ± 1.4 10.2 ± 3.2 < 0.001
Peak gradient (mmHg): 15.9 ± 9.2 38.3 ± 19.8 < 0.001
Mean gradient mmHg): 8.0 ± 4.8 18.7 ± 10.0 < 0.001
EOA (cm2): 2.0 ± 0.7 2.2 ± 0.8 ns
EOA index (cm2/m2): 1.1 ± 0.4 1.2 ± 0.4 ns
Performance index: 0.55 ± 0.16 0.59 ± 0.20 ns
Ejection fraction (%): 57.8 ± 10.5 69.1 ± 8.6 < 0.001
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In the tested patients heart rate increased by 73% and
cardiac output by 85% during DSE. An increase in heart
rate from 50-80% and cardiac output from 74-120%
have been reported in five studies using the early low
dose infusion (20 μg/kg/min) [3,4,6,7]. In three other
studies [10-12] using the high dose (40 μg/kg/min),
heart rate increased from 69-90% and cardiac output
increased from 88 - 110%. As the increase in transvalvu-
lar gradients is dependent of flow, the differences in test
conditions make comparison of data difficult.
In this study the hemodynamic characteristics of the St.
Jude Regent bileaflet prostheses were examined in 66
patients with valve sizes from 19-25 mm. As expected
mean transvalvular gradients at rest and during stress
decreased with increasing valve size. In the 21 mm sized
prostheses mean pressure gradient increased from 9.2 ±
6.6 mmHg to 21.1 ± 10.0 mmHg. These values are asso-
ciated with a relatively mild transprosthetic gradient at
rest and during peak stress. A few studies have previously
compared various valve types based on stress tests.
Slightly lower pressure gradients and slightly smaller
EOA during stress, have been reported by Izzat et al in
two studies in 1995 and 1996 [3,4]. These studies
included 9 and 10 patients and were performed using
bileaflet mechanical valves (Carbo Medics 19-21 mm
valves and St. Jude 21 mm). Contrary, a few studies using
DSE in 21 mm sized prostheses have documented higher
pressure gradients. Kadir et al [8] using the Sorin 21 mm
valve, documented that mean transvalvular gradient
increased from 15.6 ± 5.3 to 35.4 ± 11.9 mmHg during
DSE. In another study [6] using Medtronic Intact aortic
bioprotheses, mean transvalvular gradient increased from
19.1 ± 5.1 to 33.2 ± 7.7 mmHg.
In our study the aortic valve area (EOA) remained rela-
tively unchanged despite a significant increase in transpro-
thetic gradients. This finding is in line with the majority of
other studies [3,4,6,9,12], and is possibly explained because
mechanical components are less prone to accompany lar-
ger stroke volumes by increasing the EOA.
An EOAI greater than 0.85-0.9 cm2/m2 has been sug-
gested to minimize the effects of transprosthetic gradi-
ent and patient-to-prosthesis mismatch [1,21]. In our
study the values for EOAI were above this limit in all
sizes both at rest and during peak stress, indicating a
favorable hemodynamic performance.
To our knowledge this study is one among the largest
using DSE in the postoperative assessment patients fol-
lowing aortic valve replaement. In our experience DSE
can be performed safely in all patients and maximum
stress can be achieved in the majority of patients. Our
study demonstrates excellent hemodynamic results for
the St. Jude Medical Regent valve, even at small size,
and a significant reduction in the left ventricular mass
after one year.
Conclusion
The Dobutamine test induces a substantial stress, well
suitable for echocardiographic assessment of prosthesis
valve function and can be performed in the majority of
the patients. The changes in pressure gradients add to
the hemodynamic characteristics of the various valve
sizes. In our patients the St. Jude Regent valve per-
formed satisfactory at rest and under pharmacological
stress situation.
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